Selling And Administration Expenses Cambiamento Data
AbbVie USD 3.61B 273M 2023-12
Agios Pharmaceuticals USD 35.3M 9.48M 2023-12
Alnylam Pharmaceuticals USD 198.12M 1.05M 2023-12
Amgen USD 1.76B 424M 2023-12
Astellas Pharma JPY 179.28B 11.1B 2023-09
AstraZeneca USD 3.91B 194M 2023-09
Biogen USD 608.5M 179.7M 2023-12
BioMarin Pharmaceutical USD 275.02M 51.1M 2023-12
Bluebird Bio USD 40.7M 354K 2023-09
Bristol-Myers Squibb USD 2.06B 126M 2023-12
Eli Lilly USD 1.92B 120.7M 2023-12
Esperion Therapeutics USD 33.24M 719K 2023-09
Gilead Sciences USD 1.61B 293M 2023-12
GlaxoSmithKline GBP 2.18B 6M 2023-09
Incyte USD 293.86M 25.97M 2023-12
Ionis Pharmaceuticals USD 71.01M 1.06M 2023-12
J&J USD 5.81B 410M 2023-12
Kyowa Hakko Kirin JPY 34.25B 3.85B 2023-09
Merck USD 2.75B 272M 2023-12
Moderna USD 470M 28M 2023-12
Neurocrine Biosciences USD 204.2M 17.6M 2023-09
Opthea USD 10.62M 6.87M 2023-06
Pfizer USD 4.47B 1.27B 2023-12
Regeneron Pharmaceuticals USD 737.7M 97.2M 2023-12
Roche Holding CHF 6.51B 26M 2023-06
Sarepta Therapeutics USD 120.89M 2.33M 2023-09
Teva Pharmaceutical Industries USD 844M 66M 2023-09
Ultragenyx Pharmaceutical USD 76.83M 1.92M 2023-12
United Therapeutics USD 128.6M 1000K 2023-12
Vertex Pharmaceuticals USD 263.8M 1.2M 2023-09



Regeneron Pharmaceuticals Spese Di Vendita E Di Amministrazione - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Mar 2024.